Insights Series S2E8: Prof Benza about the move towards innovative trial designs in PAH studies

25 Jan 2024


Raymond L. Benza, Chief of Pulmonary Hypertension at Mount Sinai Health System, New York City, Principal Investigator of the Phase II study of CS1, and member of Cereno’s Scientific Advisory Board, speaks about how the industry moves toward innovative trial designs in pulmonary arterial hypertension (PAH) studies.

Watch here >

English subtitles are available.

This video is episode 8 in the Insights Series season 2 and was recorded at the ESC Congress in August 2023.